High-Dose Therapy and Autologous Peripheral-Blood Stem-Cell Transplantation As Salvage Treatment for HIV-Associated Lymphoma in Patients Receiving Highly Active Antiretroviral TherapyAlessandro Re, Giuseppe Rossi, Chiara Cattaneo et al.|Journal of Clinical Oncology|2003Cited by 129
Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA studyGiuseppe Rossi, Wilma Barcellini, Francesca Romana Mauro et al.|Blood|2018Cited by 89
Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centersWilma Barcellini, Agostino Cortelezzi, Anna Zaninoni et al.|American Journal of Hematology|2018Cited by 80
A Recent Update of Three Consecutive Prospective Trials with High-Dose Therapy and Autograft, without or with Rituximab, as Primary Treatment for Advanced-Stage Follicular Lymphoma (FL) Shows a Sizeable Group of Patients Surviving in Continuous Complete Remission up to 16 Years After the End of Treatment: Should We Still Consider FL An Incurable Disease ?.Corrado Tarella, Paolo Corradini, Marco Ladetto et al.|Blood|2009Cited by 4